# Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

> **NCT01329900** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 50 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Ofatumumab
- **DRUG:** Ifosfamide
- **DRUG:** Etoposide
- **DRUG:** Mesna
- **DRUG:** G-CSF
- **PROCEDURE:** Stem Cell Collection

## Key facts

- **NCT ID:** NCT01329900
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-22
- **Primary completion:** 2019-07-21
- **Final completion:** 2019-07-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329900, "Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01329900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*